# Which Apparatus for Inhaled Pentamidine?

> **NCT02277808** · EARLY_PHASE1 · UNKNOWN · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 10 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 500mg Amikacine (Amukin®) diluted in 4mL NaCl (0,9%)
- **DEVICE:** Respirgard II
- **DEVICE:** Isoneb®

## Key facts

- **NCT ID:** NCT02277808
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2014-10
- **Final completion:** —
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02277808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02277808, "Which Apparatus for Inhaled Pentamidine?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02277808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*